Skip to main content

Advertisement

Log in

3BDO Alleviates Seizures and Improves Cognitive Function by Regulating Autophagy in Pentylenetetrazol (PTZ)-Kindled Epileptic Mice Model

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

3-benzyl-5-((2-nitrophenoxy) methyl)-dihydrofuran-2(3 H)-one (3BDO) is a mTOR agonist that inhibits autophagy. The main purpose of this study is to investigate the effects of 3BDO on seizure and cognitive function by autophagy regulation in pentylenetetrazol (PTZ)-kindled epileptic mice model. The PTZ-kindled epileptic mice model was used in study. The behavioral changes and electroencephalogram (EEG) of the mice in each group were observed. The cognitive functions were tested by Morris water maze test. The loss of hippocampal neurons was detected by hematoxylin-eosin (HE) staining and immunofluorescence analysis. Immunohistochemistry, western blot and q-PCR were employed to detect the expression of autophagy-related proteins and mTOR in the hippocampus and cortex. Less seizures, increased hippocampal neurons and reduced astrocytes of hippocampus were observed in the 3BDO-treated epileptic mice than in the PTZ-kindled epileptic mice. Morris water maze test results showed that 3BDO significantly improved the cognitive function of the PTZ-kindled epileptic mice. Western blot analyses and q-PCR revealed that 3BDO inhibited the expression of LC3, Beclin-1, Atg5, Atg7 and p-ULK1/ULK1, but increased that of p-mTOR/mTOR, p-P70S6K/P70S6K in the hippocampus and temporal lobe cortex of epileptic mice. Immunohistochemistry and immunofluorescence also showed 3BDO inhibited the LC3 expression and increased the mTOR expression in the hippocampus of epileptic mice. In addition, the autophagy activator EN6 reversed the decrease in the 3BDO-induced autophagy and aggravated the seizures and cognitive dysfunction in the epileptic mice. 3BDO regulates autophagy by activating the mTOR signaling pathway in PTZ-kindled epileptic mice model, thereby alleviating hippocampus neuronal loss and astrocytes proliferation, reducing seizures and effectively improving cognitive function. Therefore, 3BDO may have potential value in the treatment of epilepsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data Availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Chen S, Chen Y, Zhang Y, Kuang X, Liu Y, Guo M, Ma L, Zhang D, Li Q (2020) Iron metabolism and ferroptosis in epilepsy. FrontNeurosci 14:601193

    Google Scholar 

  2. Muhlhofer W, Tan Y, Mueller S, Knowlton R (2017) MRI-negative temporal lobe epilepsy-What do we know? Epilepsia 58:727–742

    Article  PubMed  Google Scholar 

  3. Thom M (2014) Review: Hippocampal sclerosis in epilepsy: a neuropathology review. Neuropathol Appl Neurobiol 40:520–543

    Article  PubMed  PubMed Central  Google Scholar 

  4. Malmgren K, Thom M (2012) Hippocampal sclerosis–origins and imaging. Epilepsia. 53:19–33. https://doi.org/10.1111/j.1528-1167.2012.03610.x

    Article  CAS  PubMed  Google Scholar 

  5. Thijs R, Surges R, O’Brien T, Sander J (2019) Epilepsy in adults. Lancet (London England) 393:689–701

    Article  PubMed  Google Scholar 

  6. Moshé S, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet (London England) 385:884–898

    Article  PubMed  Google Scholar 

  7. Kaur J, Famta P, Famta M, Mehta M, Satija S, Sharma N, Vyas M, Khatik G, Chellappan D, Dua K, Khurana N (2021) Potential anti-epileptic phytoconstituents: An updated review. J Ethnopharmacol 268:113565

    Article  CAS  PubMed  Google Scholar 

  8. Bortz J (2003) Neuropsychiatric and memory issues in epilepsy. Mayo Clinic Proceedings 78:781–787

    Article  PubMed  Google Scholar 

  9. Gan J, Qu Y, Li J, Zhao F, Mu D (2015) An evaluation of the links between microRNA, autophagy, and epilepsy. Rev Neurosci 26:225–237

    Article  CAS  PubMed  Google Scholar 

  10. Giorgi F, Biagioni F, Lenzi P, Frati A, Fornai F (2015) The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations. J Neural Transm 122:849–862

    Article  PubMed  Google Scholar 

  11. Kaushik S, Tasset I, Arias E, Pampliega O, Wong E, Martinez-Vicente M, Cuervo A (2021) Autophagy and the hallmarks of aging. Ageing Res Rev 72:101468

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Pondrelli F, Muccioli L, Licchetta L, Mostacci B, Zenesini C, Tinuper P, Vignatelli L, Bisulli F (2021) Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis. Orphanet J Rare Dis 16:362

    Article  PubMed  PubMed Central  Google Scholar 

  13. Marsan E, Baulac S (2018) Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy. Neuropathol Appl Neurobiol 44:6–17

    Article  CAS  PubMed  Google Scholar 

  14. Lu D, Karas P, Krueger D, Weiner H (2018) Central nervous system manifestations of tuberous sclerosis complex. Am J Med Genet C 178:291–298

    Article  Google Scholar 

  15. Dong Y, Wang S, Zhang T, Zhao X, Liu X, Cao L, Chi Z (2013) Ascorbic acid ameliorates seizures and brain damage in rats through inhibiting autophagy. Brain Res 1535:115–123

    Article  CAS  PubMed  Google Scholar 

  16. Rami A, Benz A, Niquet J, Langhagen A (2016) Axonal accumulation of lysosomal-associated membrane protein 1 (LAMP1) Accompanying alterations of autophagy dynamics in the rat hippocampus upon seizure-induced injury. Neurochem Res 41:53–63

    Article  CAS  PubMed  Google Scholar 

  17. Şentürk M, Lin G, Zuo Z, Mao D, Watson E, Mikos A, Bellen H (2019) Ubiquilins regulate autophagic flux through mTOR signalling and lysosomal acidification. Nat Cell Biol 21:384–396

    Article  PubMed  PubMed Central  Google Scholar 

  18. Brugarolas J, Lei K, Hurley R, Manning B, Reiling J, Hafen E, Witters L, Ellisen L, Kaelin W (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 18:2893–2904

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sax J, Dash B, Hong R, Dicker D, El-Deiry W (2002) The cyclin-dependent kinase inhibitor butyrolactone is a potent inhibitor of p21 (WAF1/CIP1 expression). Cell Cycle (Georgetown, Tex). 1:90–96

    CAS  PubMed  Google Scholar 

  20. Wang W, Liu X, Zhang Y, Zhao J, Zhao B, Zhang S, Miao J (2007) Both senescence and apoptosis induced by deprivation of growth factors were inhibited by a novel butyrolactone derivative through depressing integrin beta4 in vascular endothelial cells. Endothelium 14:325–332

    Article  CAS  PubMed  Google Scholar 

  21. Lin C, Fang J, Xiang Q, Zhou R, Yang L (2021) Exendin-4 promotes autophagy to relieve lipid deposition in a NAFLD cell model by activating AKT/mTOR signaling pathway. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 41:1073–1078

    CAS  PubMed  Google Scholar 

  22. Liang Q, Dong W, Ou M, Li Z, Liu C, Wang F, Liu Y, Wang W (2021) Penaeus vannameimiR-151 affects low-temperature tolerance of by modulating autophagy under low-temperature stress. Front Cell Dev Biol 9:595108

    Article  PubMed  PubMed Central  Google Scholar 

  23. Peng N, Meng N, Wang S, Zhao F, Zhao J, Su L, Zhang S, Zhang Y, Zhao B, Miao J (2014) An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E−/− mice. Sci Rep 4:5519

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Wei L, Yang H, Xie Z, Yang S, Yang H, Zhao C, Wang P, Xu S, Miao J, Zhao B, Bi J (2012) A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model. J Alzheimer’s Dis 30:531–543

    Article  CAS  Google Scholar 

  25. Racine R (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr  Clin Neurophysiol 32:281–294

    Article  CAS  PubMed  Google Scholar 

  26. Biggane J, Xu K, Goldenstein B, Davis K, Luger E, Davis B, Jurgens C, Perez D, Porter J, Doze V (2022) Pharmacological characterization of the α-adrenergic receptor inhibiting rat hippocampal CA3 epileptiform activity: comparison of ligand efficacy and potency. J Recept Signal Transduct Res. https://doi.org/10.1080/10799893.2022.2110896

    Article  PubMed  Google Scholar 

  27. Hu A, Yuan H, Qin Y, Zhu Y, Zhang L, Chen Q, Wu L (2022) Lipopolysaccharide (LPS) increases susceptibility to epilepsy via interleukin-1 type 1 receptor signaling. Brain Res 1793:148052

    Article  CAS  PubMed  Google Scholar 

  28. Chung C, Shin H, Berdan C, Ford B, Ward C, Olzmann J, Zoncu R, Nomura D (2019) Covalent targeting of the vacuolar H-ATPase activates autophagy via mTORC1 inhibition. Nat Chem Biol 15:776–785

    Article  CAS  PubMed  Google Scholar 

  29. Singh T, Mishra A, Goel R (2021) PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability. Metab Brain Dis. https://doi.org/10.1007/s11011-021-00823-3

    Article  PubMed  Google Scholar 

  30. Zhao X, Su L, He X, Zhao B, Miao J (2020) CA7-4Long noncoding RNA promotes autophagy and apoptosis via sponging and in high glucose-induced vascular endothelial cells. Autophagy 16:70–85

    Article  CAS  PubMed  Google Scholar 

  31. Meng N, Zhao J, Su L, Zhao B, Zhang Y, Zhang S, Miao J (2012) A butyrolactone derivative suppressed lipopolysaccharide-induced autophagic injury through inhibiting the autoregulatory loop of p8 and p53 in vascular endothelial cells. Int J Biochem Cell Biol 44:311–319

    Article  CAS  PubMed  Google Scholar 

  32. Huang B, Meng N, Zhao B, Zhao J, Zhang Y, Zhang S, Miao J (2009) Protective effects of a synthesized butyrolactone derivative against chloroquine-induced autophagic vesicle accumulation and the disturbance of mitochondrial membrane potential and Na+, K+- ATPase activity in vascular endothelial cells. Chem Res Toxicol 22:471–475

    Article  CAS  PubMed  Google Scholar 

  33. Yang S, Wang S, Peng N, Xie Z, Wang P, Zhao C, Wei L, Yang H, Zhao B, Miao J, Bi J (2012) Butyrolactone derivative 3-benzyl-5-((2-nitrophenoxy) methyl)-dihydrofuran-2(3H)-one protects against amyloid-β peptides-induced cytotoxicity in PC12 cells. J Alzheimer’s Dis 28:345–356

    Article  Google Scholar 

Download references

Funding

This study was supported by grants from the Natural Science Foundation of Hainan Province (819QN370 and 819QN367), the National Natural Science Foundation of China (81760244, 81960249 and 82260270), Hainan Provincial Key Research and Development Plan of China (ZDYF2019124 and ZDYF2022SHFZ109), Epilepsy Research Science Innovation Group of Hainan Medical University (2022), Hainan Province Clinical Medical Center (2021) and the Excellent Talent Team of Hainan Province (No. QRCBT202121).

Author information

Authors and Affiliations

Authors

Contributions

MG conceived the experimental design, performed the project research, and participated in the experimental process. MG and SC searched the available literature, sorted the references, and wrote this manuscript. JL and HC were involved in the literature search. QL and DJ coordinated and supervised the study, provided research direction, designed the research strategy, and modified the final draft. All authors have carefully read and confirmed the final version of the manuscript.

Corresponding authors

Correspondence to Dandan Jia or Qifu Li.

Ethics declarations

Conflict of interest

The authors declare no potential conflict of interest. We confirm that we have read the Journal’s position on potential ethical issues involved in the publication and confirm compliance with those guidelines.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, M., Chen, S., Lao, J. et al. 3BDO Alleviates Seizures and Improves Cognitive Function by Regulating Autophagy in Pentylenetetrazol (PTZ)-Kindled Epileptic Mice Model. Neurochem Res 47, 3777–3791 (2022). https://doi.org/10.1007/s11064-022-03778-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-022-03778-8

Keywords

Navigation